Received: 10 February 2022
Revised: 22 February 2022
Accepted: 1 March 2022
First Online: 18 April 2022
Compliance with ethical standards
: KK reports grants and personal fees from Daiichi Sankyo, Bayer Inc., grants and personal fees from Nippon Boehringer Ingelheim, Kyowa Kirin, Sumitomo Dainippon Pharma, Astellas Pharma, and Sanofi, and personal fees from Takeda Pharmaceutical outside of the submitted work.